Virtual Diagnostic Market by Application (Ophthalmology, Cardiology, Pulmonology, Gastroenterology, Otolaryngology, Dermatology, Geriatric, Neurology, Orthopedics, Mental Health, Women's Health) by End-User (Physicians/Clinicians (Providers, Hospitals (Urgent and Acute Care Centers, Clinics, Primary Care Centers, Senior Care Facilities, Home–Based care, Others) Payers (Insurance Companies, Others)) Diagnostic Centers, Research Laboratories and Organizations, Others) by Type (Device/Wearable-based and Mobile App-based); By Region (U.S., Canada, Mexico, Rest of North America, France, UK, Germany, Spain, Italy, Nordic Countries, Benelux Union, Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Rest of Asia Pacific, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of MEA, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2020 - 2028

Report ID :AMI-792 | Category : Healthcare & IT | Published Date : January, 2021 | Pages : 402 | Format :PDF

Industry Trends

Global virtual diagnostic market is expected to reach US$ 1409.57 million by 2028, growing at a CAGR of 16.71% over the forecast period. Emergency treatment is provided by virtual diagnostics solution providers for patients suffering from chronic illnesses and other high-risk patients who require regular medical consultation exams. Virtual diagnostics helps patients to interact with physicians according to the need of patient. As the next enhancement to the virtual care, healthcare providers see point-of-care testing and remote diagnostic services as primary solutions in order to provide efficient care to the patients. Through this, patients may see a doctor online for a troublesome health condition and have home laboratories and tests, thus, increasing patient interaction and telehealth satisfaction.

The growth of the demand for virtual diagnostics is driven by the rising prevalence of chronic health conditions. Other factors which boost the growth of these solutions are poor health conditions, shortage of doctors and medical personnel in routine diagnosis, these factors are raising the need for virtual diagnosis. Virtual diagnostics are successful in meeting the demand for such diagnostic products. Different factors, including growing understanding of early disease detection and increasing demand for accessible diagnostics are responsible for market development. Progress in technology such as artificial intelligence and machine learning is expected to generate lucrative opportunities in the near future for virtual diagnostic market.

This system, however, is new and includes several challenges which includes low virtual diagnosis accuracy and growing privacy issues, these factors may restrict market development. However, shortage of doctors and medical personnel may alleviate the demand for virtual diagnostic in the years to come. In addition, the rising number of diabetic patients worldwide combined with an increasing preference for self-diagnosis and technological developments in diagnostic technology will fuel the global demand for virtual diagnostics in the coming years. Also, the rise in the geriatric population worldwide and the growth in the prevalence of chronic and infectious diseases worldwide would increase the adoption of virtual diagnostics solutions.

The invention of pathological AI to aid diagnosis would effectively minimise workload of healthcare workers. In addition, increasing adoption of fully automated diagnostic laboratory instruments which are more versatile, high-performance, help minimise hands-on time and eliminate batch testing, would increase the demand for virtual diagnostics in the near future. Also, there is an increase in demand for virtual diagnostics to reduce the false positive detection rate which is expected to accelerate the global market of virtual diagnostics over the forecast period.

The growth in geriatric population globally would fuel the demand for virtual diagnostic over the forecast period. There are 703 million individuals aged 65 or older, according to the United Nations, a figure which is estimated to reach 1.5 billion by 2050. According to the current demographic forecasts and predictions by 2050, 1 in 6 individuals in the world will be over 65 years of age, up from 1 in 11 in 2019. The new estimates also indicate that in the next 30 years, the number of individuals aged 80 or over will triple. This will boost the demand for virtual diagnostic solutions as these solutions helps the patients in eliminating the visits to doctor’s office thus saving time and effort.

Growing adoption of AI in the virtual diagnostic field will fuel the growth of virtual diagnostic industry over the years to come. AI allows predictive diagnosis to be created by algorithms to help doctors choose which patients to prioritise. AI allows doctors to determine which patients to prioritise and assist doctors in the diagnosis of complex or rare diseases. AI diagnostic technology will dramatically reduce the workload of physicians and the processing of image data and the analysis of findings that need to be solved. The use of technology is encouraged by the rise in chronic diseases in rural as well as urban areas and by internet infiltration. In remote areas, the government also supports the launch of such projects and offers financial assistance to families. Smartphones are becoming a norm for the population. Virtual diagnostic solutions enhance clinical results and are time-efficient as well. Virtual diagnostics allows for a higher per-day number of consultations. In response to the growing health epidemic, market leaders are creating customer-centred applications to help users communicate with a professional as per the requirement of patients.

Stakeholders are fighting against time to diagnose a vast number of individuals to curb the spread as the coronavirus pandemic intensifies. The smallest of symptoms trigger a great deal of worry during a pandemic. However, as hospitals and clinics are busy with infected patients, visiting a doctor is not always a viable choice. Virtual diagnostic solutions are experiencing massive demand, especially during the pandemic of COVID-19. The virus has resulted in the deterioration of the healthcare system in different economies. In the current scenario hospitals are filled with infected persons, and rapid adoption of these solutions is being witnessed by the virtual diagnostic industry. Solutions for virtual health risk assessment that enable individuals to get a quick, primary diagnosis of their symptoms alleviate their concern and ease the burden on healthcare systems.

The consumer demand would be fuelled by an increase in public understanding of the benefits of technology, an increase in the need for point-of-care diagnosis and treatment, and the increasing trend of personalised medicine. Rapid technological development provides a lucrative growth of these solutions and also helps to collect an unprecedented volume of data while maintaining safety and security. The market for virtual diagnostics is very broad, with many small and medium-sized manufacturers responsible for a large share of the global market. Throughout the supply chain, the suppliers participating in the industry are desegregated. The main businesses in the sector are well-equipped with large companies and are also active in various research and development activities.

Application Insights

In application the cardiology segment will exhibit significant revenue over the forecast period. One of the leading drivers of the market is the increase in cardiology incidence and the increasing concern for frequent consultations among heart patients. These patients are easily vulnerable to the COVID-19 virus and should have no interaction with patients suffering from the virus in overflowing hospitals. Virtual diagnostic technology thus provides them with a unique way of consulting and preserving their wellbeing with their physicians.

End-User Insights

In end user the physicians/clinicians segment will lead the market over the period. The hospital segment is rapidly introducing technology in remote areas to treat and consult patients. Several hospitals are integrating IoT with their equipment with exhausted personnel, but recent advances are expected to increase funding for the healthcare sector which will in turn boost the demand for the virtual diagnostic industry. The implementation of virtual diagnostics which can recognise the problems of all patients with the aid of AI and machine learning will boom in the clinic section.

Type Insights

In the type segment device/wearable based virtual diagnostic solutions are gaining momentum in the market. The players in the market are providing wearable and devices in order to monitor health and also these devices can provide insights on the patient data in order to make analysis. There is an increase in prevalence of app based virtual diagnostic solution in the market. The adoption of app based solutions in order to provide care has increased globally.

Regional Insights

Over the forecast period, North America region will witness a high growth due to the increased adoption of emerging technology in healthcare systems in the region. Moreover, Asia Pacific region will exhibit a significant CAGR over the forecast period due to the presence of a high geriatric population; the industry is experiencing high demand in this region. In the healthcare sector, the introduction of smart technology would fuel consumer demand. The Chinese government has invested more in the hospital's infrastructure to boost its virtual diagnostic business. Developing countries like Indonesia and Malaysia are providing virtual diagnostics to help low-income individuals gain access to better healthcare.

Virtual Diagnostic Market Revenue & Forecast, (US$ Million), 2020 – 2028

Competitive Landscape

The report provides both, qualitative and quantitative research on virtual diagnostic market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contacts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.

The major players operating in the market include AliveCor, Inc., CapsoVision, Inc., Digital Diagnostics Inc., dSPACE GmbH, Eyenuk, Inc., hearX IP (Pty) Ltd., Hill-Rom Services, Inc., Infermedica, Medtronic, ResApp Health Limited, Sight Diagnostics Ltd, SkinVision, Teckel Medical and other market participants.

Virtual Diagnostic Market:

By Application
- Ophthalmology
- Cardiology
- Pulmonology
- Gastroenterology
- Otolaryngology
- Dermatology
- Geriatric
- Neurology
- Orthopedics
- Mental Health
- Women's Health
By End-User
- Physicians/Clinicians
- Providers
- Hospitals
- Urgent and Acute Care Centers
- Clinics
- Primary Care Centers
- Senior Care Facilities
- Home –Based care
- Others
- Payers
- Insurance Companies
- Others
- Diagnostic Centers
- Research Laboratories and Organizations
- Others
By Type
- Device/Wearable-based
- Mobile App-based
By Region:
- North America
  - U.S.
  - Canada
  - Mexico
  - Rest of North America
- Europe
  - France
  - The UK
  - Spain
  - Germany
  - Italy
  - Nordic Countries
    - Denmark
    - Finland
    - Iceland
    - Sweden
    - Norway
  - Benelux Union
    - Belgium
    - The Netherlands
    - Luxembourg
  - Rest of Europe
- Asia Pacific
  - China
  - Japan
  - India
  - New Zealand
  - Australia
  - South Korea
  - Southeast Asia
    - Indonesia
    - Thailand
    - Malaysia
    - Singapore
    - Rest of Southeast Asia
  - Rest of Asia Pacific
- Middle East & Africa
  - Saudi Arabia
  - UAE
  - Egypt
  - Kuwait
  - South Africa
  - Rest of Middle East & Africa
- Latin America
  - Brazil
  - Argentina
  - Rest of Latin America

Table of Contents

1. Market Scope

1.1. Market Segmentation

1.2. Years Considered

1.2.1. Historic Years: 2015 - 2018

1.2.2. Base Year: 2019

1.2.3. Forecast Years: 2020 – 2028

2. Key Target Audiences

3. Research Methodology

3.1. Primary Research

3.1.1. Research Questionnaire

3.1.2. Global Percentage Breakdown

3.1.3. Primary Interviews: Key Opinion Leaders (KOLs)

3.2. Secondary Research

3.2.1. Paid Databases

3.2.2. Secondary Sources

3.3. Market Size Estimates

3.3.1. Top-Down Approach

3.3.2. Bottom-Up Approach

3.4. Data Triangulation Methodology

3.5. Research Assumptions

4. Recommendations and Insights from AMI’s Perspective**

5. Holistic Overview of Virtual Diagnostic Market

6. Market Synopsis: Virtual Diagnostic Market

7. Virtual Diagnostic Market Analysis: Qualitative Perspective

7.1. Introduction

7.1.1. Product Definition

7.1.2. Industry Development

7.2. Market Dynamics

7.2.1. Drivers

7.2.2. Restraints

7.2.3. Opportunities

7.3. Trends in Virtual Diagnostic Market

7.4. Market Determinants Radar Chart

7.5. Macro-Economic and Micro-Economic Indicators: Virtual Diagnostic Market

7.6. Porter’s Five Force Analysis

7.7. Impact of Covid-19 on Virtual Diagnostic Market

8. Global Virtual Diagnostic Market Analysis and Forecasts, 2020 – 2028

8.1. Overview

8.1.1. Global Virtual Diagnostic Market Revenue (US$ Mn)

8.2. Global Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application

8.2.1. Ophthalmology

8.2.1.1. Definition

8.2.1.2. Market Estimation and Penetration, 2015 – 2019

8.2.1.3. Market Forecast, 2020 – 2028

8.2.1.4. Compound Annual Growth Rate (CAGR)

8.2.1.5. Regional Bifurcation

8.2.1.5.1. North America

8.2.1.5.1.1. Market Estimation, 2015 – 2019

8.2.1.5.1.2. Market Forecast, 2020 – 2028

8.2.1.5.2. Europe

8.2.1.5.2.1. Market Estimation, 2015 – 2019

8.2.1.5.2.2. Market Forecast, 2020 – 2028

8.2.1.5.3. Asia Pacific

8.2.1.5.3.1. Market Estimation, 2015 – 2019

8.2.1.5.3.2. Market Forecast, 2020 – 2028

8.2.1.5.4. Middle East and Africa

8.2.1.5.4.1. Market Estimation, 2015 – 2019

8.2.1.5.4.2. Market Forecast, 2020 – 2028

8.2.1.5.5. Latin America

8.2.1.5.5.1. Market Estimation, 2015 – 2019

8.2.1.5.5.2. Market Forecast, 2020 – 2028

8.2.2. Cardiology

8.2.2.1. Definition

8.2.2.2. Market Estimation and Penetration, 2015 – 2019

8.2.2.3. Market Forecast, 2020 – 2028

8.2.2.4. Compound Annual Growth Rate (CAGR)

8.2.2.5. Regional Bifurcation

8.2.2.5.1. North America

8.2.2.5.1.1. Market Estimation, 2015 – 2019

8.2.2.5.1.2. Market Forecast, 2020 – 2028

8.2.2.5.2. Europe

8.2.2.5.2.1. Market Estimation, 2015 – 2019

8.2.2.5.2.2. Market Forecast, 2020 – 2028

8.2.2.5.3. Asia Pacific

8.2.2.5.3.1. Market Estimation, 2015 – 2019

8.2.2.5.3.2. Market Forecast, 2020 – 2028

8.2.2.5.4. Middle East and Africa

8.2.2.5.4.1. Market Estimation, 2015 – 2019

8.2.2.5.4.2. Market Forecast, 2020 – 2028

8.2.2.5.5. Latin America

8.2.2.5.5.1. Market Estimation, 2015 – 2019

8.2.2.5.5.2. Market Forecast, 2020 – 2028

8.2.3. Pulmonology

8.2.3.1. Definition

8.2.3.2. Market Estimation and Penetration, 2015 – 2019

8.2.3.3. Market Forecast, 2020 – 2028

8.2.3.4. Compound Annual Growth Rate (CAGR)

8.2.3.5. Regional Bifurcation

8.2.3.5.1. North America

8.2.3.5.1.1. Market Estimation, 2015 – 2019

8.2.3.5.1.2. Market Forecast, 2020 – 2028

8.2.3.5.2. Europe

8.2.3.5.2.1. Market Estimation, 2015 – 2019

8.2.3.5.2.2. Market Forecast, 2020 – 2028

8.2.3.5.3. Asia Pacific

8.2.3.5.3.1. Market Estimation, 2015 – 2019

8.2.3.5.3.2. Market Forecast, 2020 – 2028

8.2.3.5.4. Middle East and Africa

8.2.3.5.4.1. Market Estimation, 2015 – 2019

8.2.3.5.4.2. Market Forecast, 2020 – 2028

8.2.3.5.5. Latin America

8.2.3.5.5.1. Market Estimation, 2015 – 2019

8.2.3.5.5.2. Market Forecast, 2020 – 2028

8.2.4. Gastroenterology

8.2.4.1. Definition

8.2.4.2. Market Estimation and Penetration, 2015 – 2019

8.2.4.3. Market Forecast, 2020 – 2028

8.2.4.4. Compound Annual Growth Rate (CAGR)

8.2.4.5. Regional Bifurcation

8.2.4.5.1. North America

8.2.4.5.1.1. Market Estimation, 2015 – 2019

8.2.4.5.1.2. Market Forecast, 2020 – 2028

8.2.4.5.2. Europe

8.2.4.5.2.1. Market Estimation, 2015 – 2019

8.2.4.5.2.2. Market Forecast, 2020 – 2028

8.2.4.5.3. Asia Pacific

8.2.4.5.3.1. Market Estimation, 2015 – 2019

8.2.4.5.3.2. Market Forecast, 2020 – 2028

8.2.4.5.4. Middle East and Africa

8.2.4.5.4.1. Market Estimation, 2015 – 2019

8.2.4.5.4.2. Market Forecast, 2020 – 2028

8.2.4.5.5. Latin America

8.2.4.5.5.1. Market Estimation, 2015 – 2019

8.2.4.5.5.2. Market Forecast, 2020 – 2028

8.2.5. Otolaryngology

8.2.5.1. Definition

8.2.5.2. Market Estimation and Penetration, 2015 – 2019

8.2.5.3. Market Forecast, 2020 – 2028

8.2.5.4. Compound Annual Growth Rate (CAGR)

8.2.5.5. Regional Bifurcation

8.2.5.5.1. North America

8.2.5.5.1.1. Market Estimation, 2015 – 2019

8.2.5.5.1.2. Market Forecast, 2020 – 2028

8.2.5.5.2. Europe

8.2.5.5.2.1. Market Estimation, 2015 – 2019

8.2.5.5.2.2. Market Forecast, 2020 – 2028

8.2.5.5.3. Asia Pacific

8.2.5.5.3.1. Market Estimation, 2015 – 2019

8.2.5.5.3.2. Market Forecast, 2020 – 2028

8.2.5.5.4. Middle East and Africa

8.2.5.5.4.1. Market Estimation, 2015 – 2019

8.2.5.5.4.2. Market Forecast, 2020 – 2028

8.2.5.5.5. Latin America

8.2.5.5.5.1. Market Estimation, 2015 – 2019

8.2.5.5.5.2. Market Forecast, 2020 – 2028

8.2.6. Dermatology

8.2.6.1. Definition

8.2.6.2. Market Estimation and Penetration, 2015 – 2019

8.2.6.3. Market Forecast, 2020 – 2028

8.2.6.4. Compound Annual Growth Rate (CAGR)

8.2.6.5. Regional Bifurcation

8.2.6.5.1. North America

8.2.6.5.1.1. Market Estimation, 2015 – 2019

8.2.6.5.1.2. Market Forecast, 2020 – 2028

8.2.6.5.2. Europe

8.2.6.5.2.1. Market Estimation, 2015 – 2019

8.2.6.5.2.2. Market Forecast, 2020 – 2028

8.2.6.5.3. Asia Pacific

8.2.6.5.3.1. Market Estimation, 2015 – 2019

8.2.6.5.3.2. Market Forecast, 2020 – 2028

8.2.6.5.4. Middle East and Africa

8.2.6.5.4.1. Market Estimation, 2015 – 2019

8.2.6.5.4.2. Market Forecast, 2020 – 2028

8.2.6.5.5. Latin America

8.2.6.5.5.1. Market Estimation, 2015 – 2019

8.2.6.5.5.2. Market Forecast, 2020 – 2028

8.2.7. Geriatric

8.2.7.1. Definition

8.2.7.2. Market Estimation and Penetration, 2015 – 2019

8.2.7.3. Market Forecast, 2020 – 2028

8.2.7.4. Compound Annual Growth Rate (CAGR)

8.2.7.5. Regional Bifurcation

8.2.7.5.1. North America

8.2.7.5.1.1. Market Estimation, 2015 – 2019

8.2.7.5.1.2. Market Forecast, 2020 – 2028

8.2.7.5.2. Europe

8.2.7.5.2.1. Market Estimation, 2015 – 2019

8.2.7.5.2.2. Market Forecast, 2020 – 2028

8.2.7.5.3. Asia Pacific

8.2.7.5.3.1. Market Estimation, 2015 – 2019

8.2.7.5.3.2. Market Forecast, 2020 – 2028

8.2.7.5.4. Middle East and Africa

8.2.7.5.4.1. Market Estimation, 2015 – 2019

8.2.7.5.4.2. Market Forecast, 2020 – 2028

8.2.7.5.5. Latin America

8.2.7.5.5.1. Market Estimation, 2015 – 2019

8.2.7.5.5.2. Market Forecast, 2020 – 2028

8.2.8. Neurology

8.2.8.1. Definition

8.2.8.2. Market Estimation and Penetration, 2015 – 2019

8.2.8.3. Market Forecast, 2020 – 2028

8.2.8.4. Compound Annual Growth Rate (CAGR)

8.2.8.5. Regional Bifurcation

8.2.8.5.1. North America

8.2.8.5.1.1. Market Estimation, 2015 – 2019

8.2.8.5.1.2. Market Forecast, 2020 – 2028

8.2.8.5.2. Europe

8.2.8.5.2.1. Market Estimation, 2015 – 2019

8.2.8.5.2.2. Market Forecast, 2020 – 2028

8.2.8.5.3. Asia Pacific

8.2.8.5.3.1. Market Estimation, 2015 – 2019

8.2.8.5.3.2. Market Forecast, 2020 – 2028

8.2.8.5.4. Middle East and Africa

8.2.8.5.4.1. Market Estimation, 2015 – 2019

8.2.8.5.4.2. Market Forecast, 2020 – 2028

8.2.8.5.5. Latin America

8.2.8.5.5.1. Market Estimation, 2015 – 2019

8.2.8.5.5.2. Market Forecast, 2020 – 2028

8.2.9. Orthopedics

8.2.9.1. Definition

8.2.9.2. Market Estimation and Penetration, 2015 – 2019

8.2.9.3. Market Forecast, 2020 – 2028

8.2.9.4. Compound Annual Growth Rate (CAGR)

8.2.9.5. Regional Bifurcation

8.2.9.5.1. North America

8.2.9.5.1.1. Market Estimation, 2015 – 2019

8.2.9.5.1.2. Market Forecast, 2020 – 2028

8.2.9.5.2. Europe

8.2.9.5.2.1. Market Estimation, 2015 – 2019

8.2.9.5.2.2. Market Forecast, 2020 – 2028

8.2.9.5.3. Asia Pacific

8.2.9.5.3.1. Market Estimation, 2015 – 2019

8.2.9.5.3.2. Market Forecast, 2020 – 2028

8.2.9.5.4. Middle East and Africa

8.2.9.5.4.1. Market Estimation, 2015 – 2019

8.2.9.5.4.2. Market Forecast, 2020 – 2028

8.2.9.5.5. Latin America

8.2.9.5.5.1. Market Estimation, 2015 – 2019

8.2.9.5.5.2. Market Forecast, 2020 – 2028

8.2.10. Mental Health

8.2.10.1. Definition

8.2.10.2. Market Estimation and Penetration, 2015 – 2019

8.2.10.3. Market Forecast, 2020 – 2028

8.2.10.4. Compound Annual Growth Rate (CAGR)

8.2.10.5. Regional Bifurcation

8.2.10.5.1. North America

8.2.10.5.1.1. Market Estimation, 2015 – 2019

8.2.10.5.1.2. Market Forecast, 2020 – 2028

8.2.10.5.2. Europe

8.2.10.5.2.1. Market Estimation, 2015 – 2019

8.2.10.5.2.2. Market Forecast, 2020 – 2028

8.2.10.5.3. Asia Pacific

8.2.10.5.3.1. Market Estimation, 2015 – 2019

8.2.10.5.3.2. Market Forecast, 2020 – 2028

8.2.10.5.4. Middle East and Africa

8.2.10.5.4.1. Market Estimation, 2015 – 2019

8.2.10.5.4.2. Market Forecast, 2020 – 2028

8.2.10.5.5. Latin America

8.2.10.5.5.1. Market Estimation, 2015 – 2019

8.2.10.5.5.2. Market Forecast, 2020 – 2028

8.2.11. Women's Health

8.2.11.1. Definition

8.2.11.2. Market Estimation and Penetration, 2015 – 2019

8.2.11.3. Market Forecast, 2020 – 2028

8.2.11.4. Compound Annual Growth Rate (CAGR)

8.2.11.5. Regional Bifurcation

8.2.11.5.1. North America

8.2.11.5.1.1. Market Estimation, 2015 – 2019

8.2.11.5.1.2. Market Forecast, 2020 – 2028

8.2.11.5.2. Europe

8.2.11.5.2.1. Market Estimation, 2015 – 2019

8.2.11.5.2.2. Market Forecast, 2020 – 2028

8.2.11.5.3. Asia Pacific

8.2.11.5.3.1. Market Estimation, 2015 – 2019

8.2.11.5.3.2. Market Forecast, 2020 – 2028

8.2.11.5.4. Middle East and Africa

8.2.11.5.4.1. Market Estimation, 2015 – 2019

8.2.11.5.4.2. Market Forecast, 2020 – 2028

8.2.11.5.5. Latin America

8.2.11.5.5.1. Market Estimation, 2015 – 2019

8.2.11.5.5.2. Market Forecast, 2020 – 2028

8.2.12. Others

8.2.12.1. Definition

8.2.12.2. Market Estimation and Penetration, 2015 – 2019

8.2.12.3. Market Forecast, 2020 – 2028

8.2.12.4. Compound Annual Growth Rate (CAGR)

8.2.12.5. Regional Bifurcation

8.2.12.5.1. North America

8.2.12.5.1.1. Market Estimation, 2015 – 2019

8.2.12.5.1.2. Market Forecast, 2020 – 2028

8.2.12.5.2. Europe

8.2.12.5.2.1. Market Estimation, 2015 – 2019

8.2.12.5.2.2. Market Forecast, 2020 – 2028

8.2.12.5.3. Asia Pacific

8.2.12.5.3.1. Market Estimation, 2015 – 2019

8.2.12.5.3.2. Market Forecast, 2020 – 2028

8.2.12.5.4. Middle East and Africa

8.2.12.5.4.1. Market Estimation, 2015 – 2019

8.2.12.5.4.2. Market Forecast, 2020 – 2028

8.2.12.5.5. Latin America

8.2.12.5.5.1. Market Estimation, 2015 – 2019

8.2.12.5.5.2. Market Forecast, 2020 – 2028

8.3. Key Segment for Channeling Investments

8.3.1. By Application

9. Global Virtual Diagnostic Market Analysis and Forecasts, 2020 – 2028

9.1. Overview

9.2. Global Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User

9.2.1. Physicians/Clinicians

9.2.1.1. Definition

9.2.1.2. Market Estimation and Penetration, 2015 – 2019

9.2.1.3. Market Forecast, 2020 – 2028

9.2.1.4. Compound Annual Growth Rate (CAGR)

9.2.1.5. Regional Bifurcation

9.2.1.5.1. North America

9.2.1.5.1.1. Market Estimation, 2015 – 2019

9.2.1.5.1.2. Market Forecast, 2020 – 2028

9.2.1.5.2. Europe

9.2.1.5.2.1. Market Estimation, 2015 – 2019

9.2.1.5.2.2. Market Forecast, 2020 – 2028

9.2.1.5.3. Asia Pacific

9.2.1.5.3.1. Market Estimation, 2015 – 2019

9.2.1.5.3.2. Market Forecast, 2020 – 2028

9.2.1.5.4. Middle East and Africa

9.2.1.5.4.1. Market Estimation, 2015 – 2019

9.2.1.5.4.2. Market Forecast, 2020 – 2028

9.2.1.5.5. Latin America

9.2.1.5.5.1. Market Estimation, 2015 – 2019

9.2.1.5.5.2. Market Forecast, 2020 – 2028

9.2.2. Providers (Definition, Market Estimation and Penetration, 2015 – 2019, Market Estimation (2015 – 2019), Market Forecast (2020 – 2028), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on Hospitals, Urgent and Acute Care Centers, Clinics, Primary Care Centers, Senior Care Facilities, Home –Based care, Others)

9.2.2.1. Hospitals

9.2.2.2. Urgent and Acute Care Centers

9.2.2.3. Clinics

9.2.2.4. Primary Care Centers

9.2.2.5. Senior Care Facilities

9.2.2.6. Home –Based care

9.2.2.7. Others

9.2.3. Payers (Definition, Market Estimation and Penetration, 2015 – 2019, Market Estimation (2015 – 2019), Market Forecast (2020 – 2028), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on Insurance Companies, Others)

9.2.3.1. Insurance Companies

9.2.3.2. Others

9.2.4. Diagnostic Centers

9.2.4.1. Definition

9.2.4.2. Market Estimation and Penetration, 2015 – 2019

9.2.4.3. Market Forecast, 2020 – 2028

9.2.4.4. Compound Annual Growth Rate (CAGR)

9.2.4.5. Regional Bifurcation

9.2.4.5.1. North America

9.2.4.5.1.1. Market Estimation, 2015 – 2019

9.2.4.5.1.2. Market Forecast, 2020 – 2028

9.2.4.5.2. Europe

9.2.4.5.2.1. Market Estimation, 2015 – 2019

9.2.4.5.2.2. Market Forecast, 2020 – 2028

9.2.4.5.3. Asia Pacific

9.2.4.5.3.1. Market Estimation, 2015 – 2019

9.2.4.5.3.2. Market Forecast, 2020 – 2028

9.2.4.5.4. Middle East and Africa

9.2.4.5.4.1. Market Estimation, 2015 – 2019

9.2.4.5.4.2. Market Forecast, 2020 – 2028

9.2.4.5.5. Latin America

9.2.4.5.5.1. Market Estimation, 2015 – 2019

9.2.4.5.5.2. Market Forecast, 2020 – 2028

9.2.5. Research Laboratories and Organizations

9.2.5.1. Definition

9.2.5.2. Market Estimation and Penetration, 2015 – 2019

9.2.5.3. Market Forecast, 2020 – 2028

9.2.5.4. Compound Annual Growth Rate (CAGR)

9.2.5.5. Regional Bifurcation

9.2.5.5.1. North America

9.2.5.5.1.1. Market Estimation, 2015 – 2019

9.2.5.5.1.2. Market Forecast, 2020 – 2028

9.2.5.5.2. Europe

9.2.5.5.2.1. Market Estimation, 2015 – 2019

9.2.5.5.2.2. Market Forecast, 2020 – 2028

9.2.5.5.3. Asia Pacific

9.2.5.5.3.1. Market Estimation, 2015 – 2019

9.2.5.5.3.2. Market Forecast, 2020 – 2028

9.2.5.5.4. Middle East and Africa

9.2.5.5.4.1. Market Estimation, 2015 – 2019

9.2.5.5.4.2. Market Forecast, 2020 – 2028

9.2.5.5.5. Latin America

9.2.5.5.5.1. Market Estimation, 2015 – 2019

9.2.5.5.5.2. Market Forecast, 2020 – 2028

9.2.6. Others

9.2.6.1. Definition

9.2.6.2. Market Estimation and Penetration, 2015 – 2019

9.2.6.3. Market Forecast, 2020 – 2028

9.2.6.4. Compound Annual Growth Rate (CAGR)

9.2.6.5. Regional Bifurcation

9.2.6.5.1. North America

9.2.6.5.1.1. Market Estimation, 2015 – 2019

9.2.6.5.1.2. Market Forecast, 2020 – 2028

9.2.6.5.2. Europe

9.2.6.5.2.1. Market Estimation, 2015 – 2019

9.2.6.5.2.2. Market Forecast, 2020 – 2028

9.2.6.5.3. Asia Pacific

9.2.6.5.3.1. Market Estimation, 2015 – 2019

9.2.6.5.3.2. Market Forecast, 2020 – 2028

9.2.6.5.4. Middle East and Africa

9.2.6.5.4.1. Market Estimation, 2015 – 2019

9.2.6.5.4.2. Market Forecast, 2020 – 2028

9.2.6.5.5. Latin America

9.2.6.5.5.1. Market Estimation, 2015 – 2019

9.2.6.5.5.2. Market Forecast, 2020 – 2028

9.3. Key Segment for Channeling Investments

9.3.1. By End-User

10. Global Virtual Diagnostic Market Analysis and Forecasts, 2020 – 2028

10.1. Overview

10.2. Global Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type

10.2.1. Device/Wearable-based

10.2.1.1. Definition

10.2.1.2. Market Estimation and Penetration, 2015 – 2019

10.2.1.3. Market Forecast, 2020 – 2028

10.2.1.4. Compound Annual Growth Rate (CAGR)

10.2.1.5. Regional Bifurcation

10.2.1.5.1. North America

10.2.1.5.1.1. Market Estimation, 2015 – 2019

10.2.1.5.1.2. Market Forecast, 2020 – 2028

10.2.1.5.2. Europe

10.2.1.5.2.1. Market Estimation, 2015 – 2019

10.2.1.5.2.2. Market Forecast, 2020 – 2028

10.2.1.5.3. Asia Pacific

10.2.1.5.3.1. Market Estimation, 2015 – 2019

10.2.1.5.3.2. Market Forecast, 2020 – 2028

10.2.1.5.4. Middle East and Africa

10.2.1.5.4.1. Market Estimation, 2015 – 2019

10.2.1.5.4.2. Market Forecast, 2020 – 2028

10.2.1.5.5. Latin America

10.2.1.5.5.1. Market Estimation, 2015 – 2019

10.2.1.5.5.2. Market Forecast, 2020 – 2028

10.2.2. Mobile App-based

10.2.2.1. Definition

10.2.2.2. Market Estimation and Penetration, 2015 – 2019

10.2.2.3. Market Forecast, 2020 – 2028

10.2.2.4. Compound Annual Growth Rate (CAGR)

10.2.2.5. Regional Bifurcation

10.2.2.5.1. North America

10.2.2.5.1.1. Market Estimation, 2015 – 2019

10.2.2.5.1.2. Market Forecast, 2020 – 2028

10.2.2.5.2. Europe

10.2.2.5.2.1. Market Estimation, 2015 – 2019

10.2.2.5.2.2. Market Forecast, 2020 – 2028

10.2.2.5.3. Asia Pacific

10.2.2.5.3.1. Market Estimation, 2015 – 2019

10.2.2.5.3.2. Market Forecast, 2020 – 2028

10.2.2.5.4. Middle East and Africa

10.2.2.5.4.1. Market Estimation, 2015 – 2019

10.2.2.5.4.2. Market Forecast, 2020 – 2028

10.2.2.5.5. Latin America

10.2.2.5.5.1. Market Estimation, 2015 – 2019

10.2.2.5.5.2. Market Forecast, 2020 – 2028

10.3. Key Segment for Channeling Investments

10.3.1. By Type

11. North America Virtual Diagnostic Market Analysis and Forecasts, 2020 - 2028

11.1. Overview

11.1.1. North America Virtual Diagnostic Market Revenue (US$ Mn)

11.2. North America Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application

11.2.1. Ophthalmology

11.2.2. Cardiology

11.2.3. Pulmonology

11.2.4. Gastroenterology

11.2.5. Otolaryngology

11.2.6. Dermatology

11.2.7. Geriatric

11.2.8. Neurology

11.2.9. Orthopedics

11.2.10. Mental Health

11.2.11. Women's Health

11.2.12. Others

11.3. North America Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User

11.3.1. Physicians/Clinicians

11.3.2. Providers

11.3.2.1. Hospitals

11.3.2.2. Urgent and Acute Care Centers

11.3.2.3. Clinics

11.3.2.4. Primary Care Centers

11.3.2.5. Senior Care Facilities

11.3.2.6. Home –Based care

11.3.2.7. Others

11.3.3. Payers

11.3.3.1. Insurance Companies

11.3.3.2. Others

11.3.4. Diagnostic Centers

11.3.5. Research Laboratories and Organizations

11.3.6. Others

11.4. North America Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type

11.4.1. Device/Wearable-based

11.4.2. Mobile App-based

11.5. North America Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Country

11.5.1. U.S

11.5.1.1. U.S Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application

11.5.1.1.1. Ophthalmology

11.5.1.1.2. Cardiology

11.5.1.1.3. Pulmonology

11.5.1.1.4. Gastroenterology

11.5.1.1.5. Otolaryngology

11.5.1.1.6. Dermatology

11.5.1.1.7. Geriatric

11.5.1.1.8. Neurology

11.5.1.1.9. Orthopedics

11.5.1.1.10. Mental Health

11.5.1.1.11. Women's Health

11.5.1.1.12. Others

11.5.1.2. U.S Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User

11.5.1.2.1. Physicians/Clinicians

11.5.1.2.2. Providers

11.5.1.2.2.1. Hospitals

11.5.1.2.2.2. Urgent and Acute Care Centers

11.5.1.2.2.3. Clinics

11.5.1.2.2.4. Primary Care Centers

11.5.1.2.2.5. Senior Care Facilities

11.5.1.2.2.6. Home –Based care

11.5.1.2.2.7. Others

11.5.1.2.3. Payers

11.5.1.2.3.1. Insurance Companies

11.5.1.2.3.2. Others

11.5.1.2.4. Diagnostic Centers

11.5.1.2.5. Research Laboratories and Organizations

11.5.1.2.6. Others

11.5.1.3. U.S Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type

11.5.1.3.1. Device/Wearable-based

11.5.1.3.2. Mobile App-based

11.5.2. Canada

11.5.2.1. Canada Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application

11.5.2.1.1. Ophthalmology

11.5.2.1.2. Cardiology

11.5.2.1.3. Pulmonology

11.5.2.1.4. Gastroenterology

11.5.2.1.5. Otolaryngology

11.5.2.1.6. Dermatology

11.5.2.1.7. Geriatric

11.5.2.1.8. Neurology

11.5.2.1.9. Orthopedics

11.5.2.1.10. Mental Health

11.5.2.1.11. Women's Health

11.5.2.1.12. Others

11.5.2.2. Canada Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User

11.5.2.2.1. Physicians/Clinicians

11.5.2.2.2. Providers

11.5.2.2.2.1. Hospitals

11.5.2.2.2.2. Urgent and Acute Care Centers

11.5.2.2.2.3. Clinics

11.5.2.2.2.4. Primary Care Centers

11.5.2.2.2.5. Senior Care Facilities

11.5.2.2.2.6. Home –Based care

11.5.2.2.2.7. Others

11.5.2.2.3. Payers

11.5.2.2.3.1. Insurance Companies

11.5.2.2.3.2. Others

11.5.2.2.4. Diagnostic Centers

11.5.2.2.5. Research Laboratories and Organizations

11.5.2.2.6. Others

11.5.2.3. Canada Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type

11.5.2.3.1. Device/Wearable-based

11.5.2.3.2. Mobile App-based

11.5.3. Mexico

11.5.3.1. Mexico Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application

11.5.3.1.1. Ophthalmology

11.5.3.1.2. Cardiology

11.5.3.1.3. Pulmonology

11.5.3.1.4. Gastroenterology

11.5.3.1.5. Otolaryngology

11.5.3.1.6. Dermatology

11.5.3.1.7. Geriatric

11.5.3.1.8. Neurology

11.5.3.1.9. Orthopedics

11.5.3.1.10. Mental Health

11.5.3.1.11. Women's Health

11.5.3.1.12. Others

11.5.3.2. Mexico Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User

11.5.3.2.1. Physicians/Clinicians

11.5.3.2.2. Providers

11.5.3.2.2.1. Hospitals

11.5.3.2.2.2. Urgent and Acute Care Centers

11.5.3.2.2.3. Clinics

11.5.3.2.2.4. Primary Care Centers

11.5.3.2.2.5. Senior Care Facilities

11.5.3.2.2.6. Home –Based care

11.5.3.2.2.7. Others

11.5.3.2.3. Payers

11.5.3.2.3.1. Insurance Companies

11.5.3.2.3.2. Others

11.5.3.2.4. Diagnostic Centers

11.5.3.2.5. Research Laboratories and Organizations

11.5.3.2.6. Others

11.5.3.3. Mexico Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type

11.5.3.3.1. Device/Wearable-based

11.5.3.3.2. Mobile App-based

11.5.4. Rest of North America

11.5.4.1. Rest of North America Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application

11.5.4.1.1. Ophthalmology

11.5.4.1.2. Cardiology

11.5.4.1.3. Pulmonology

11.5.4.1.4. Gastroenterology

11.5.4.1.5. Otolaryngology

11.5.4.1.6. Dermatology

11.5.4.1.7. Geriatric

11.5.4.1.8. Neurology

11.5.4.1.9. Orthopedics

11.5.4.1.10. Mental Health

11.5.4.1.11. Women's Health

11.5.4.1.12. Others

11.5.4.2. Rest of North America Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User

11.5.4.2.1. Physicians/Clinicians

11.5.4.2.2. Providers

11.5.4.2.2.1. Hospitals

11.5.4.2.2.2. Urgent and Acute Care Centers

11.5.4.2.2.3. Clinics

11.5.4.2.2.4. Primary Care Centers

11.5.4.2.2.5. Senior Care Facilities

11.5.4.2.2.6. Home –Based care

11.5.4.2.2.7. Others

11.5.4.2.3. Payers

11.5.4.2.3.1. Insurance Companies

11.5.4.2.3.2. Others

11.5.4.2.4. Diagnostic Centers

11.5.4.2.5. Research Laboratories and Organizations

11.5.4.2.6. Others

11.5.4.3. Rest of North America Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type

11.5.4.3.1. Device/Wearable-based

11.5.4.3.2. Mobile App-based

11.6. Key Segment for Channeling Investments

11.6.1. By Country

11.6.2. By Application

11.6.3. By End-User

11.6.4. By Type

12. Europe Virtual Diagnostic Market Analysis and Forecasts, 2020 - 2028

12.1. Overview

12.1.1. Europe Virtual Diagnostic Market Revenue (US$ Mn)

12.2. Europe Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application

12.2.1. Ophthalmology

12.2.2. Cardiology

12.2.3. Pulmonology

12.2.4. Gastroenterology

12.2.5. Otolaryngology

12.2.6. Dermatology

12.2.7. Geriatric

12.2.8. Neurology

12.2.9. Orthopedics

12.2.10. Mental Health

12.2.11. Women's Health

12.2.12. Others

12.3. Europe Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User

12.3.1. Physicians/Clinicians

12.3.2. Providers

12.3.2.1. Hospitals

12.3.2.2. Urgent and Acute Care Centers

12.3.2.3. Clinics

12.3.2.4. Primary Care Centers

12.3.2.5. Senior Care Facilities

12.3.2.6. Home –Based care

12.3.2.7. Others

12.3.3. Payers

12.3.3.1. Insurance Companies

12.3.3.2. Others

12.3.4. Diagnostic Centers

12.3.5. Research Laboratories and Organizations

12.3.6. Others

12.4. Europe Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type

12.4.1. Device/Wearable-based

12.4.2. Mobile App-based

12.5. Europe Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Country

12.5.1. France

12.5.1.1. France Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application

12.5.1.1.1. Ophthalmology

12.5.1.1.2. Cardiology

12.5.1.1.3. Pulmonology

12.5.1.1.4. Gastroenterology

12.5.1.1.5. Otolaryngology

12.5.1.1.6. Dermatology

12.5.1.1.7. Geriatric

12.5.1.1.8. Neurology

12.5.1.1.9. Orthopedics

12.5.1.1.10. Mental Health

12.5.1.1.11. Women's Health

12.5.1.1.12. Others

12.5.1.2. France Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User

12.5.1.2.1. Physicians/Clinicians

12.5.1.2.2. Providers

12.5.1.2.2.1. Hospitals

12.5.1.2.2.2. Urgent and Acute Care Centers

12.5.1.2.2.3. Clinics

12.5.1.2.2.4. Primary Care Centers

12.5.1.2.2.5. Senior Care Facilities

12.5.1.2.2.6. Home –Based care

12.5.1.2.2.7. Others

12.5.1.2.3. Payers

12.5.1.2.3.1. Insurance Companies

12.5.1.2.3.2. Others

12.5.1.2.4. Diagnostic Centers

12.5.1.2.5. Research Laboratories and Organizations

12.5.1.2.6. Others

12.5.1.3. France Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type

12.5.1.3.1. Device/Wearable-based

12.5.1.3.2. Mobile App-based

12.5.2. The UK

12.5.2.1. The UK Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application

12.5.2.1.1. Ophthalmology

12.5.2.1.2. Cardiology

12.5.2.1.3. Pulmonology

12.5.2.1.4. Gastroenterology

12.5.2.1.5. Otolaryngology

12.5.2.1.6. Dermatology

12.5.2.1.7. Geriatric

12.5.2.1.8. Neurology

12.5.2.1.9. Orthopedics

12.5.2.1.10. Mental Health

12.5.2.1.11. Women's Health

12.5.2.1.12. Others

12.5.2.2. The UK Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User

12.5.2.2.1. Physicians/Clinicians

12.5.2.2.2. Providers

12.5.2.2.2.1. Hospitals

12.5.2.2.2.2. Urgent and Acute Care Centers

12.5.2.2.2.3. Clinics

12.5.2.2.2.4. Primary Care Centers

12.5.2.2.2.5. Senior Care Facilities

12.5.2.2.2.6. Home –Based care

12.5.2.2.2.7. Others

12.5.2.2.3. Payers

12.5.2.2.3.1. Insurance Companies

12.5.2.2.3.2. Others

12.5.2.2.4. Diagnostic Centers

12.5.2.2.5. Research Laboratories and Organizations

12.5.2.2.6. Others

12.5.2.3. The UK Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type

12.5.2.3.1. Device/Wearable-based

12.5.2.3.2. Mobile App-based

12.5.3. Spain

12.5.3.1. Spain Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application

12.5.3.1.1. Ophthalmology

12.5.3.1.2. Cardiology

12.5.3.1.3. Pulmonology

12.5.3.1.4. Gastroenterology

12.5.3.1.5. Otolaryngology

12.5.3.1.6. Dermatology

12.5.3.1.7. Geriatric

12.5.3.1.8. Neurology

12.5.3.1.9. Orthopedics

12.5.3.1.10. Mental Health

12.5.3.1.11. Women's Health

12.5.3.1.12. Others

12.5.3.2. Spain Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User

12.5.3.2.1. Physicians/Clinicians

12.5.3.2.2. Providers

12.5.3.2.2.1. Hospitals

12.5.3.2.2.2. Urgent and Acute Care Centers

12.5.3.2.2.3. Clinics

12.5.3.2.2.4. Primary Care Centers

12.5.3.2.2.5. Senior Care Facilities

12.5.3.2.2.6. Home –Based care

12.5.3.2.2.7. Others

12.5.3.2.3. Payers

12.5.3.2.3.1. Insurance Companies

12.5.3.2.3.2. Others

12.5.3.2.4. Diagnostic Centers

12.5.3.2.5. Research Laboratories and Organizations

12.5.3.2.6. Others

12.5.3.3. Spain Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type

12.5.3.3.1. Device/Wearable-based

12.5.3.3.2. Mobile App-based

12.5.4. Germany

12.5.4.1. Germany Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application

12.5.4.1.1. Ophthalmology

12.5.4.1.2. Cardiology

12.5.4.1.3. Pulmonology

12.5.4.1.4. Gastroenterology

12.5.4.1.5. Otolaryngology

12.5.4.1.6. Dermatology

12.5.4.1.7. Geriatric

12.5.4.1.8. Neurology

12.5.4.1.9. Orthopedics

12.5.4.1.10. Mental Health

12.5.4.1.11. Women's Health

12.5.4.1.12. Others

12.5.4.2. Germany Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User

12.5.4.2.1. Physicians/Clinicians

12.5.4.2.2. Providers

12.5.4.2.2.1. Hospitals

12.5.4.2.2.2. Urgent and Acute Care Centers

12.5.4.2.2.3. Clinics

12.5.4.2.2.4. Primary Care Centers

12.5.4.2.2.5. Senior Care Facilities

12.5.4.2.2.6. Home –Based care

12.5.4.2.2.7. Others

12.5.4.2.3. Payers

12.5.4.2.3.1. Insurance Companies

12.5.4.2.3.2. Others

12.5.4.2.4. Diagnostic Centers

12.5.4.2.5. Research Laboratories and Organizations

12.5.4.2.6. Others

12.5.4.3. Germany Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type

12.5.4.3.1. Device/Wearable-based

12.5.4.3.2. Mobile App-based

12.5.5. Italy

12.5.5.1. Italy Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application

12.5.5.1.1. Ophthalmology

12.5.5.1.2. Cardiology

12.5.5.1.3. Pulmonology

12.5.5.1.4. Gastroenterology

12.5.5.1.5. Otolaryngology

12.5.5.1.6. Dermatology

12.5.5.1.7. Geriatric

12.5.5.1.8. Neurology

12.5.5.1.9. Orthopedics

12.5.5.1.10. Mental Health

12.5.5.1.11. Women's Health

12.5.5.1.12. Others

12.5.5.2. Italy Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User

12.5.5.2.1. Physicians/Clinicians

12.5.5.2.2. Providers

12.5.5.2.2.1. Hospitals

12.5.5.2.2.2. Urgent and Acute Care Centers

12.5.5.2.2.3. Clinics

12.5.5.2.2.4. Primary Care Centers

12.5.5.2.2.5. Senior Care Facilities

12.5.5.2.2.6. Home –Based care

12.5.5.2.2.7. Others

12.5.5.2.3. Payers

12.5.5.2.3.1. Insurance Companies

12.5.5.2.3.2. Others

12.5.5.2.4. Diagnostic Centers

12.5.5.2.5. Research Laboratories and Organizations

12.5.5.2.6. Others

12.5.5.3. Italy Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type

12.5.5.3.1. Device/Wearable-based

12.5.5.3.2. Mobile App-based

12.5.6. Nordic Countries

12.5.6.1. Nordic Countries Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application

12.5.6.1.1. Ophthalmology

12.5.6.1.2. Cardiology

12.5.6.1.3. Pulmonology

12.5.6.1.4. Gastroenterology

12.5.6.1.5. Otolaryngology

12.5.6.1.6. Dermatology

12.5.6.1.7. Geriatric

12.5.6.1.8. Neurology

12.5.6.1.9. Orthopedics

12.5.6.1.10. Mental Health

12.5.6.1.11. Women's Health

12.5.6.1.12. Others

12.5.6.2. Nordic Countries Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User

12.5.6.2.1. Physicians/Clinicians

12.5.6.2.2. Providers

12.5.6.2.2.1. Hospitals

12.5.6.2.2.2. Urgent and Acute Care Centers

12.5.6.2.2.3. Clinics

12.5.6.2.2.4. Primary Care Centers

12.5.6.2.2.5. Senior Care Facilities

12.5.6.2.2.6. Home –Based care

12.5.6.2.2.7. Others

12.5.6.2.3. Payers

12.5.6.2.3.1. Insurance Companies

12.5.6.2.3.2. Others

12.5.6.2.4. Diagnostic Centers

12.5.6.2.5. Research Laboratories and Organizations

12.5.6.2.6. Others

12.5.6.3. Nordic Countries Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type

12.5.6.3.1. Device/Wearable-based

12.5.6.3.2. Mobile App-based

12.5.6.4. Nordic Countries Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Country

12.5.6.4.1. Denmark

12.5.6.4.2. Finland

12.5.6.4.3. Iceland

12.5.6.4.4. Sweden

12.5.6.4.5. Norway

12.5.7. Benelux Union

12.5.7.1. Benelux Union Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application

12.5.7.1.1. Ophthalmology

12.5.7.1.2. Cardiology

12.5.7.1.3. Pulmonology

12.5.7.1.4. Gastroenterology

12.5.7.1.5. Otolaryngology

12.5.7.1.6. Dermatology

12.5.7.1.7. Geriatric

12.5.7.1.8. Neurology

12.5.7.1.9. Orthopedics

12.5.7.1.10. Mental Health

12.5.7.1.11. Women's Health

12.5.7.1.12. Others

12.5.7.2. Benelux Union Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User

12.5.7.2.1. Physicians/Clinicians

12.5.7.2.2. Providers

12.5.7.2.2.1. Hospitals

12.5.7.2.2.2. Urgent and Acute Care Centers

12.5.7.2.2.3. Clinics

12.5.7.2.2.4. Primary Care Centers

12.5.7.2.2.5. Senior Care Facilities

12.5.7.2.2.6. Home –Based care

12.5.7.2.2.7. Others

12.5.7.2.3. Payers

12.5.7.2.3.1. Insurance Companies

12.5.7.2.3.2. Others

12.5.7.2.4. Diagnostic Centers

12.5.7.2.5. Research Laboratories and Organizations

12.5.7.2.6. Others

12.5.7.3. Benelux Union Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type

12.5.7.3.1. Device/Wearable-based

12.5.7.3.2. Mobile App-based

12.5.7.4. Benelux Union Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Country

12.5.7.4.1. Belgium

12.5.7.4.2. The Netherlands

12.5.7.4.3. Luxembourg

12.5.8. Rest of Europe

12.5.8.1. Rest of Europe Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application

12.5.8.1.1. Ophthalmology

12.5.8.1.2. Cardiology

12.5.8.1.3. Pulmonology

12.5.8.1.4. Gastroenterology

12.5.8.1.5. Otolaryngology

12.5.8.1.6. Dermatology

12.5.8.1.7. Geriatric

12.5.8.1.8. Neurology

12.5.8.1.9. Orthopedics

12.5.8.1.10. Mental Health

12.5.8.1.11. Women's Health

12.5.8.1.12. Others

12.5.8.2. Rest of Europe Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User

12.5.8.2.1. Physicians/Clinicians

12.5.8.2.2. Providers

12.5.8.2.2.1. Hospitals

12.5.8.2.2.2. Urgent and Acute Care Centers

12.5.8.2.2.3. Clinics

12.5.8.2.2.4. Primary Care Centers

12.5.8.2.2.5. Senior Care Facilities

12.5.8.2.2.6. Home –Based care

12.5.8.2.2.7. Others

12.5.8.2.3. Payers

12.5.8.2.3.1. Insurance Companies

12.5.8.2.3.2. Others

12.5.8.2.4. Diagnostic Centers

12.5.8.2.5. Research Laboratories and Organizations

12.5.8.2.6. Others

12.5.8.3. Rest of Europe Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type

12.5.8.3.1. Device/Wearable-based

12.5.8.3.2. Mobile App-based

12.6. Key Segment for Channeling Investments

12.6.1. By Country

12.6.2. By Application

12.6.3. By End-User

12.6.4. By Type

13. Asia Pacific Virtual Diagnostic Market Analysis and Forecasts, 2020 - 2028

13.1. Overview

13.1.1. Asia Pacific Virtual Diagnostic Market Revenue (US$ Mn)

13.2. Asia Pacific Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application

13.2.1. Ophthalmology

13.2.2. Cardiology

13.2.3. Pulmonology

13.2.4. Gastroenterology

13.2.5. Otolaryngology

13.2.6. Dermatology

13.2.7. Geriatric

13.2.8. Neurology

13.2.9. Orthopedics

13.2.10. Mental Health

13.2.11. Women's Health

13.2.12. Others

13.3. Asia Pacific Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User

13.3.1. Physicians/Clinicians

13.3.2. Providers

13.3.2.1. Hospitals

13.3.2.2. Urgent and Acute Care Centers

13.3.2.3. Clinics

13.3.2.4. Primary Care Centers

13.3.2.5. Senior Care Facilities

13.3.2.6. Home –Based care

13.3.2.7. Others

13.3.3. Payers

13.3.3.1. Insurance Companies

13.3.3.2. Others

13.3.4. Diagnostic Centers

13.3.5. Research Laboratories and Organizations

13.3.6. Others

13.4. Asia Pacific Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type

13.4.1. Device/Wearable-based

13.4.2. Mobile App-based

13.5. Asia Pacific Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Country

13.5.1. China

13.5.1.1. China Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application

13.5.1.1.1. Ophthalmology

13.5.1.1.2. Cardiology

13.5.1.1.3. Pulmonology

13.5.1.1.4. Gastroenterology

13.5.1.1.5. Otolaryngology

13.5.1.1.6. Dermatology

13.5.1.1.7. Geriatric

13.5.1.1.8. Neurology

13.5.1.1.9. Orthopedics

13.5.1.1.10. Mental Health

13.5.1.1.11. Women's Health

13.5.1.1.12. Others

13.5.1.2. China Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User

13.5.1.2.1. Physicians/Clinicians

13.5.1.2.2. Providers

13.5.1.2.2.1. Hospitals

13.5.1.2.2.2. Urgent and Acute Care Centers

13.5.1.2.2.3. Clinics

13.5.1.2.2.4. Primary Care Centers

13.5.1.2.2.5. Senior Care Facilities

13.5.1.2.2.6. Home –Based care

13.5.1.2.2.7. Others

13.5.1.2.3. Payers

13.5.1.2.3.1. Insurance Companies

13.5.1.2.3.2. Others

13.5.1.2.4. Diagnostic Centers

13.5.1.2.5. Research Laboratories and Organizations

13.5.1.2.6. Others

13.5.1.3. China Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type

13.5.1.3.1. Device/Wearable-based

13.5.1.3.2. Mobile App-based

13.5.2. Japan

13.5.2.1. Japan Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application

13.5.2.1.1. Ophthalmology

13.5.2.1.2. Cardiology

13.5.2.1.3. Pulmonology

13.5.2.1.4. Gastroenterology

13.5.2.1.5. Otolaryngology

13.5.2.1.6. Dermatology

13.5.2.1.7. Geriatric

13.5.2.1.8. Neurology

13.5.2.1.9. Orthopedics

13.5.2.1.10. Mental Health

13.5.2.1.11. Women's Health

13.5.2.1.12. Others

13.5.2.2. Japan Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User

13.5.2.2.1. Physicians/Clinicians

13.5.2.2.2. Providers

13.5.2.2.2.1. Hospitals

13.5.2.2.2.2. Urgent and Acute Care Centers

13.5.2.2.2.3. Clinics

13.5.2.2.2.4. Primary Care Centers

13.5.2.2.2.5. Senior Care Facilities

13.5.2.2.2.6. Home –Based care

13.5.2.2.2.7. Others

13.5.2.2.3. Payers

13.5.2.2.3.1. Insurance Companies

13.5.2.2.3.2. Others

13.5.2.2.4. Diagnostic Centers

13.5.2.2.5. Research Laboratories and Organizations

13.5.2.2.6. Others

13.5.2.3. Japan Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type

13.5.2.3.1. Device/Wearable-based

13.5.2.3.2. Mobile App-based

13.5.3. India

13.5.3.1. India Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application

13.5.3.1.1. Ophthalmology

13.5.3.1.2. Cardiology

13.5.3.1.3. Pulmonology

13.5.3.1.4. Gastroenterology

13.5.3.1.5. Otolaryngology

13.5.3.1.6. Dermatology

13.5.3.1.7. Geriatric

13.5.3.1.8. Neurology

13.5.3.1.9. Orthopedics

13.5.3.1.10. Mental Health

13.5.3.1.11. Women's Health

13.5.3.1.12. Others

13.5.3.2. India Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User

13.5.3.2.1. Physicians/Clinicians

13.5.3.2.2. Providers

13.5.3.2.2.1. Hospitals

13.5.3.2.2.2. Urgent and Acute Care Centers

13.5.3.2.2.3. Clinics

13.5.3.2.2.4. Primary Care Centers

13.5.3.2.2.5. Senior Care Facilities

13.5.3.2.2.6. Home –Based care

13.5.3.2.2.7. Others

13.5.3.2.3. Payers

13.5.3.2.3.1. Insurance Companies

13.5.3.2.3.2. Others

13.5.3.2.4. Diagnostic Centers

13.5.3.2.5. Research Laboratories and Organizations

13.5.3.2.6. Others

13.5.3.3. India Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type

13.5.3.3.1. Device/Wearable-based

13.5.3.3.2. Mobile App-based

13.5.4. New Zealand

13.5.4.1. New Zealand Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application

13.5.4.1.1. Ophthalmology

13.5.4.1.2. Cardiology

13.5.4.1.3. Pulmonology

13.5.4.1.4. Gastroenterology

13.5.4.1.5. Otolaryngology

13.5.4.1.6. Dermatology

13.5.4.1.7. Geriatric

13.5.4.1.8. Neurology

13.5.4.1.9. Orthopedics

13.5.4.1.10. Mental Health

13.5.4.1.11. Women's Health

13.5.4.1.12. Others

13.5.4.2. New Zealand Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User

13.5.4.2.1. Physicians/Clinicians

13.5.4.2.2. Providers

13.5.4.2.2.1. Hospitals

13.5.4.2.2.2. Urgent and Acute Care Centers

13.5.4.2.2.3. Clinics

13.5.4.2.2.4. Primary Care Centers

13.5.4.2.2.5. Senior Care Facilities

13.5.4.2.2.6. Home –Based care

13.5.4.2.2.7. Others

13.5.4.2.3. Payers

13.5.4.2.3.1. Insurance Companies

13.5.4.2.3.2. Others

13.5.4.2.4. Diagnostic Centers

13.5.4.2.5. Research Laboratories and Organizations

13.5.4.2.6. Others

13.5.4.3. New Zealand Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type

13.5.4.3.1. Device/Wearable-based

13.5.4.3.2. Mobile App-based

13.5.5. Australia

13.5.5.1. Australia Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application

13.5.5.1.1. Ophthalmology

13.5.5.1.2. Cardiology

13.5.5.1.3. Pulmonology

13.5.5.1.4. Gastroenterology

13.5.5.1.5. Otolaryngology

13.5.5.1.6. Dermatology

13.5.5.1.7. Geriatric

13.5.5.1.8. Neurology

13.5.5.1.9. Orthopedics

13.5.5.1.10. Mental Health

13.5.5.1.11. Women's Health

13.5.5.1.12. Others

13.5.5.2. Australia Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User

13.5.5.2.1. Physicians/Clinicians

13.5.5.2.2. Providers

13.5.5.2.2.1. Hospitals

13.5.5.2.2.2. Urgent and Acute Care Centers

13.5.5.2.2.3. Clinics

13.5.5.2.2.4. Primary Care Centers

13.5.5.2.2.5. Senior Care Facilities

13.5.5.2.2.6. Home –Based care

13.5.5.2.2.7. Others

13.5.5.2.3. Payers

13.5.5.2.3.1. Insurance Companies

13.5.5.2.3.2. Others

13.5.5.2.4. Diagnostic Centers

13.5.5.2.5. Research Laboratories and Organizations

13.5.5.2.6. Others

13.5.5.3. Australia Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type

13.5.5.3.1. Device/Wearable-based

13.5.5.3.2. Mobile App-based

13.5.6. South Korea

13.5.6.1. South Korea Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application

13.5.6.1.1. Ophthalmology

13.5.6.1.2. Cardiology

13.5.6.1.3. Pulmonology

13.5.6.1.4. Gastroenterology

13.5.6.1.5. Otolaryngology

13.5.6.1.6. Dermatology

13.5.6.1.7. Geriatric

13.5.6.1.8. Neurology

13.5.6.1.9. Orthopedics

13.5.6.1.10. Mental Health

13.5.6.1.11. Women's Health

13.5.6.1.12. Others

13.5.6.2. South Korea Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User

13.5.6.2.1. Physicians/Clinicians

13.5.6.2.2. Providers

13.5.6.2.2.1. Hospitals

13.5.6.2.2.2. Urgent and Acute Care Centers

13.5.6.2.2.3. Clinics

13.5.6.2.2.4. Primary Care Centers

13.5.6.2.2.5. Senior Care Facilities

13.5.6.2.2.6. Home –Based care

13.5.6.2.2.7. Others

13.5.6.2.3. Payers

13.5.6.2.3.1. Insurance Companies

13.5.6.2.3.2. Others

13.5.6.2.4. Diagnostic Centers

13.5.6.2.5. Research Laboratories and Organizations

13.5.6.2.6. Others

13.5.6.3. South Korea Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type

13.5.6.3.1. Device/Wearable-based

13.5.6.3.2. Mobile App-based

13.5.7. Southeast Asia

13.5.7.1. Southeast Asia Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application

13.5.7.1.1. Ophthalmology

13.5.7.1.2. Cardiology

13.5.7.1.3. Pulmonology

13.5.7.1.4. Gastroenterology

13.5.7.1.5. Otolaryngology

13.5.7.1.6. Dermatology

13.5.7.1.7. Geriatric

13.5.7.1.8. Neurology

13.5.7.1.9. Orthopedics

13.5.7.1.10. Mental Health

13.5.7.1.11. Women's Health

13.5.7.1.12. Others

13.5.7.2. Southeast Asia Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User

13.5.7.2.1. Physicians/Clinicians

13.5.7.2.2. Providers

13.5.7.2.2.1. Hospitals

13.5.7.2.2.2. Urgent and Acute Care Centers

13.5.7.2.2.3. Clinics

13.5.7.2.2.4. Primary Care Centers

13.5.7.2.2.5. Senior Care Facilities

13.5.7.2.2.6. Home –Based care

13.5.7.2.2.7. Others

13.5.7.2.3. Payers

13.5.7.2.3.1. Insurance Companies

13.5.7.2.3.2. Others

13.5.7.2.4. Diagnostic Centers

13.5.7.2.5. Research Laboratories and Organizations

13.5.7.2.6. Others

13.5.7.3. Southeast Asia Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type

13.5.7.3.1. Device/Wearable-based

13.5.7.3.2. Mobile App-based

13.5.7.4. Southeast Asia Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Country

13.5.7.4.1. Indonesia

13.5.7.4.2. Thailand

13.5.7.4.3. Malaysia

13.5.7.4.4. Singapore

13.5.7.4.5. Rest of Southeast Asia

13.5.8. Rest of Asia Pacific

13.5.8.1. Rest of Asia Pacific Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application

13.5.8.1.1. Ophthalmology

13.5.8.1.2. Cardiology

13.5.8.1.3. Pulmonology

13.5.8.1.4. Gastroenterology

13.5.8.1.5. Otolaryngology

13.5.8.1.6. Dermatology

13.5.8.1.7. Geriatric

13.5.8.1.8. Neurology

13.5.8.1.9. Orthopedics

13.5.8.1.10. Mental Health

13.5.8.1.11. Women's Health

13.5.8.1.12. Others

13.5.8.2. Rest of Asia Pacific Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User

13.5.8.2.1. Physicians/Clinicians

13.5.8.2.2. Providers

13.5.8.2.2.1. Hospitals

13.5.8.2.2.2. Urgent and Acute Care Centers

13.5.8.2.2.3. Clinics

13.5.8.2.2.4. Primary Care Centers

13.5.8.2.2.5. Senior Care Facilities

13.5.8.2.2.6. Home –Based care

13.5.8.2.2.7. Others

13.5.8.2.3. Payers

13.5.8.2.3.1. Insurance Companies

13.5.8.2.3.2. Others

13.5.8.2.4. Diagnostic Centers

13.5.8.2.5. Research Laboratories and Organizations

13.5.8.2.6. Others

13.5.8.3. Rest of Asia Pacific Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type

13.5.8.3.1. Device/Wearable-based

13.5.8.3.2. Mobile App-based

13.6. Key Segment for Channeling Investments

13.6.1. By Country

13.6.2. By Application

13.6.3. By End-User

13.6.4. By Type

14. Middle East and Africa Virtual Diagnostic Market Analysis and Forecasts, 2020 - 2028

14.1. Overview

14.1.1. Middle East and Africa Virtual Diagnostic Market Revenue (US$ Mn)

14.2. Middle East and Africa Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application

14.2.1. Ophthalmology

14.2.2. Cardiology

14.2.3. Pulmonology

14.2.4. Gastroenterology

14.2.5. Otolaryngology

14.2.6. Dermatology

14.2.7. Geriatric

14.2.8. Neurology

14.2.9. Orthopedics

14.2.10. Mental Health

14.2.11. Women's Health

14.2.12. Others

14.3. Middle East and Africa Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User

14.3.1. Physicians/Clinicians

14.3.2. Providers

14.3.2.1. Hospitals

14.3.2.2. Urgent and Acute Care Centers

14.3.2.3. Clinics

14.3.2.4. Primary Care Centers

14.3.2.5. Senior Care Facilities

14.3.2.6. Home –Based care

14.3.2.7. Others

14.3.3. Payers

14.3.3.1. Insurance Companies

14.3.3.2. Others

14.3.4. Diagnostic Centers

14.3.5. Research Laboratories and Organizations

14.3.6. Others

14.4. Middle East and Africa Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type

14.4.1. Device/Wearable-based

14.4.2. Mobile App-based

14.5. Middle East and Africa Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Country

14.5.1. Saudi Arabia

14.5.1.1. Saudi Arabia Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application

14.5.1.1.1. Ophthalmology

14.5.1.1.2. Cardiology

14.5.1.1.3. Pulmonology

14.5.1.1.4. Gastroenterology

14.5.1.1.5. Otolaryngology

14.5.1.1.6. Dermatology

14.5.1.1.7. Geriatric

14.5.1.1.8. Neurology

14.5.1.1.9. Orthopedics

14.5.1.1.10. Mental Health

14.5.1.1.11. Women's Health

14.5.1.1.12. Others

14.5.1.2. Saudi Arabia Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User

14.5.1.2.1. Physicians/Clinicians

14.5.1.2.2. Providers

14.5.1.2.2.1. Hospitals

14.5.1.2.2.2. Urgent and Acute Care Centers

14.5.1.2.2.3. Clinics

14.5.1.2.2.4. Primary Care Centers

14.5.1.2.2.5. Senior Care Facilities

14.5.1.2.2.6. Home –Based care

14.5.1.2.2.7. Others

14.5.1.2.3. Payers

14.5.1.2.3.1. Insurance Companies

14.5.1.2.3.2. Others

14.5.1.2.4. Diagnostic Centers

14.5.1.2.5. Research Laboratories and Organizations

14.5.1.2.6. Others

14.5.1.3. Saudi Arabia Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type

14.5.1.3.1. Device/Wearable-based

14.5.1.3.2. Mobile App-based

14.5.2. UAE

14.5.2.1. UAE Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application

14.5.2.1.1. Ophthalmology

14.5.2.1.2. Cardiology

14.5.2.1.3. Pulmonology

14.5.2.1.4. Gastroenterology

14.5.2.1.5. Otolaryngology

14.5.2.1.6. Dermatology

14.5.2.1.7. Geriatric

14.5.2.1.8. Neurology

14.5.2.1.9. Orthopedics

14.5.2.1.10. Mental Health

14.5.2.1.11. Women's Health

14.5.2.1.12. Others

14.5.2.2. UAE Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User

14.5.2.2.1. Physicians/Clinicians

14.5.2.2.2. Providers

14.5.2.2.2.1. Hospitals

14.5.2.2.2.2. Urgent and Acute Care Centers

14.5.2.2.2.3. Clinics

14.5.2.2.2.4. Primary Care Centers

14.5.2.2.2.5. Senior Care Facilities

14.5.2.2.2.6. Home –Based care

14.5.2.2.2.7. Others

14.5.2.2.3. Payers

14.5.2.2.3.1. Insurance Companies

14.5.2.2.3.2. Others

14.5.2.2.4. Diagnostic Centers

14.5.2.2.5. Research Laboratories and Organizations

14.5.2.2.6. Others

14.5.2.3. UAE Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type

14.5.2.3.1. Device/Wearable-based

14.5.2.3.2. Mobile App-based

14.5.3. Egypt

14.5.3.1. Egypt Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application

14.5.3.1.1. Ophthalmology

14.5.3.1.2. Cardiology

14.5.3.1.3. Pulmonology

14.5.3.1.4. Gastroenterology

14.5.3.1.5. Otolaryngology

14.5.3.1.6. Dermatology

14.5.3.1.7. Geriatric

14.5.3.1.8. Neurology

14.5.3.1.9. Orthopedics

14.5.3.1.10. Mental Health

14.5.3.1.11. Women's Health

14.5.3.1.12. Others

14.5.3.2. Egypt Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User

14.5.3.2.1. Physicians/Clinicians

14.5.3.2.2. Providers

14.5.3.2.2.1. Hospitals

14.5.3.2.2.2. Urgent and Acute Care Centers

14.5.3.2.2.3. Clinics

14.5.3.2.2.4. Primary Care Centers

14.5.3.2.2.5. Senior Care Facilities

14.5.3.2.2.6. Home –Based care

14.5.3.2.2.7. Others

14.5.3.2.3. Payers

14.5.3.2.3.1. Insurance Companies

14.5.3.2.3.2. Others

14.5.3.2.4. Diagnostic Centers

14.5.3.2.5. Research Laboratories and Organizations

14.5.3.2.6. Others

14.5.3.3. Egypt Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type

14.5.3.3.1. Device/Wearable-based

14.5.3.3.2. Mobile App-based

14.5.4. Kuwait

14.5.4.1. Kuwait Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application

14.5.4.1.1. Ophthalmology

14.5.4.1.2. Cardiology

14.5.4.1.3. Pulmonology

14.5.4.1.4. Gastroenterology

14.5.4.1.5. Otolaryngology

14.5.4.1.6. Dermatology

14.5.4.1.7. Geriatric

14.5.4.1.8. Neurology

14.5.4.1.9. Orthopedics

14.5.4.1.10. Mental Health

14.5.4.1.11. Women's Health

14.5.4.1.12. Others

14.5.4.2. Kuwait Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User

14.5.4.2.1. Physicians/Clinicians

14.5.4.2.2. Providers

14.5.4.2.2.1. Hospitals

14.5.4.2.2.2. Urgent and Acute Care Centers

14.5.4.2.2.3. Clinics

14.5.4.2.2.4. Primary Care Centers

14.5.4.2.2.5. Senior Care Facilities

14.5.4.2.2.6. Home –Based care

14.5.4.2.2.7. Others

14.5.4.2.3. Payers

14.5.4.2.3.1. Insurance Companies

14.5.4.2.3.2. Others

14.5.4.2.4. Diagnostic Centers

14.5.4.2.5. Research Laboratories and Organizations

14.5.4.2.6. Others

14.5.4.3. Kuwait Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type

14.5.4.3.1. Device/Wearable-based

14.5.4.3.2. Mobile App-based

14.5.5. South Africa

14.5.5.1. South Africa Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application

14.5.5.1.1. Ophthalmology

14.5.5.1.2. Cardiology

14.5.5.1.3. Pulmonology

14.5.5.1.4. Gastroenterology

14.5.5.1.5. Otolaryngology

14.5.5.1.6. Dermatology

14.5.5.1.7. Geriatric

14.5.5.1.8. Neurology

14.5.5.1.9. Orthopedics

14.5.5.1.10. Mental Health

14.5.5.1.11. Women's Health

14.5.5.1.12. Others

14.5.5.2. South Africa Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User

14.5.5.2.1. Physicians/Clinicians

14.5.5.2.2. Providers

14.5.5.2.2.1. Hospitals

14.5.5.2.2.2. Urgent and Acute Care Centers

14.5.5.2.2.3. Clinics

14.5.5.2.2.4. Primary Care Centers

14.5.5.2.2.5. Senior Care Facilities

14.5.5.2.2.6. Home –Based care

14.5.5.2.2.7. Others

14.5.5.2.3. Payers

14.5.5.2.3.1. Insurance Companies

14.5.5.2.3.2. Others

14.5.5.2.4. Diagnostic Centers

14.5.5.2.5. Research Laboratories and Organizations

14.5.5.2.6. Others

14.5.5.3. South Africa Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type

14.5.5.3.1. Device/Wearable-based

14.5.5.3.2. Mobile App-based

14.5.6. Rest of Middle East & Africa

14.5.6.1. Rest of Middle East & Africa Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application

14.5.6.1.1. Ophthalmology

14.5.6.1.2. Cardiology

14.5.6.1.3. Pulmonology

14.5.6.1.4. Gastroenterology

14.5.6.1.5. Otolaryngology

14.5.6.1.6. Dermatology

14.5.6.1.7. Geriatric

14.5.6.1.8. Neurology

14.5.6.1.9. Orthopedics

14.5.6.1.10. Mental Health

14.5.6.1.11. Women's Health

14.5.6.1.12. Others

14.5.6.2. Rest of Middle East & Africa Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User

14.5.6.2.1. Physicians/Clinicians

14.5.6.2.2. Providers

14.5.6.2.2.1. Hospitals

14.5.6.2.2.2. Urgent and Acute Care Centers

14.5.6.2.2.3. Clinics

14.5.6.2.2.4. Primary Care Centers

14.5.6.2.2.5. Senior Care Facilities

14.5.6.2.2.6. Home –Based care

14.5.6.2.2.7. Others

14.5.6.2.3. Payers

14.5.6.2.3.1. Insurance Companies

14.5.6.2.3.2. Others

14.5.6.2.4. Diagnostic Centers

14.5.6.2.5. Research Laboratories and Organizations

14.5.6.2.6. Others

14.5.6.3. Rest of Middle East & Africa Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type

14.5.6.3.1. Device/Wearable-based

14.5.6.3.2. Mobile App-based

14.6. Key Segment for Channeling Investments

14.6.1. By Country

14.6.2. By Application

14.6.3. By End-User

14.6.4. By Type

15. Latin America Virtual Diagnostic Market Analysis and Forecasts, 2020 - 2028

15.1. Overview

15.1.1. Latin America Virtual Diagnostic Market Revenue (US$ Mn)

15.2. Latin America Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application

15.2.1. Ophthalmology

15.2.2. Cardiology

15.2.3. Pulmonology

15.2.4. Gastroenterology

15.2.5. Otolaryngology

15.2.6. Dermatology

15.2.7. Geriatric

15.2.8. Neurology

15.2.9. Orthopedics

15.2.10. Mental Health

15.2.11. Women's Health

15.2.12. Others

15.3. Latin America Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User

15.3.1. Physicians/Clinicians

15.3.2. Providers

15.3.2.1. Hospitals

15.3.2.2. Urgent and Acute Care Centers

15.3.2.3. Clinics

15.3.2.4. Primary Care Centers

15.3.2.5. Senior Care Facilities

15.3.2.6. Home –Based care

15.3.2.7. Others

15.3.3. Payers

15.3.3.1. Insurance Companies

15.3.3.2. Others

15.3.4. Diagnostic Centers

15.3.5. Research Laboratories and Organizations

15.3.6. Others

15.4. Latin America Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type

15.4.1. Device/Wearable-based

15.4.2. Mobile App-based

15.5. Latin America Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Country

15.5.1. Brazil

15.5.1.1. Brazil Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application

15.5.1.1.1. Ophthalmology

15.5.1.1.2. Cardiology

15.5.1.1.3. Pulmonology

15.5.1.1.4. Gastroenterology

15.5.1.1.5. Otolaryngology

15.5.1.1.6. Dermatology

15.5.1.1.7. Geriatric

15.5.1.1.8. Neurology

15.5.1.1.9. Orthopedics

15.5.1.1.10. Mental Health

15.5.1.1.11. Women's Health

15.5.1.1.12. Others

15.5.1.2. Brazil Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User

15.5.1.2.1. Physicians/Clinicians

15.5.1.2.2. Providers

15.5.1.2.2.1. Hospitals

15.5.1.2.2.2. Urgent and Acute Care Centers

15.5.1.2.2.3. Clinics

15.5.1.2.2.4. Primary Care Centers

15.5.1.2.2.5. Senior Care Facilities

15.5.1.2.2.6. Home –Based care

15.5.1.2.2.7. Others

15.5.1.2.3. Payers

15.5.1.2.3.1. Insurance Companies

15.5.1.2.3.2. Others

15.5.1.2.4. Diagnostic Centers

15.5.1.2.5. Research Laboratories and Organizations

15.5.1.2.6. Others

15.5.1.3. Brazil Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type

15.5.1.3.1. Device/Wearable-based

15.5.1.3.2. Mobile App-based

15.5.2. Argentina

15.5.2.1. Argentina Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application

15.5.2.1.1. Ophthalmology

15.5.2.1.2. Cardiology

15.5.2.1.3. Pulmonology

15.5.2.1.4. Gastroenterology

15.5.2.1.5. Otolaryngology

15.5.2.1.6. Dermatology

15.5.2.1.7. Geriatric

15.5.2.1.8. Neurology

15.5.2.1.9. Orthopedics

15.5.2.1.10. Mental Health

15.5.2.1.11. Women's Health

15.5.2.1.12. Others

15.5.2.2. Argentina Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User

15.5.2.2.1. Physicians/Clinicians

15.5.2.2.2. Providers

15.5.2.2.2.1. Hospitals

15.5.2.2.2.2. Urgent and Acute Care Centers

15.5.2.2.2.3. Clinics

15.5.2.2.2.4. Primary Care Centers

15.5.2.2.2.5. Senior Care Facilities

15.5.2.2.2.6. Home –Based care

15.5.2.2.2.7. Others

15.5.2.2.3. Payers

15.5.2.2.3.1. Insurance Companies

15.5.2.2.3.2. Others

15.5.2.2.4. Diagnostic Centers

15.5.2.2.5. Research Laboratories and Organizations

15.5.2.2.6. Others

15.5.2.3. Argentina Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type

15.5.2.3.1. Device/Wearable-based

15.5.2.3.2. Mobile App-based

15.5.3. Rest of Latin America

15.5.3.1. Rest of Latin America Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application

15.5.3.1.1. Ophthalmology

15.5.3.1.2. Cardiology

15.5.3.1.3. Pulmonology

15.5.3.1.4. Gastroenterology

15.5.3.1.5. Otolaryngology

15.5.3.1.6. Dermatology

15.5.3.1.7. Geriatric

15.5.3.1.8. Neurology

15.5.3.1.9. Orthopedics

15.5.3.1.10. Mental Health

15.5.3.1.11. Women's Health

15.5.3.1.12. Others

15.5.3.2. Rest of Latin America Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User

15.5.3.2.1. Physicians/Clinicians

15.5.3.2.2. Providers

15.5.3.2.2.1. Hospitals

15.5.3.2.2.2. Urgent and Acute Care Centers

15.5.3.2.2.3. Clinics

15.5.3.2.2.4. Primary Care Centers

15.5.3.2.2.5. Senior Care Facilities

15.5.3.2.2.6. Home –Based care

15.5.3.2.2.7. Others

15.5.3.2.3. Payers

15.5.3.2.3.1. Insurance Companies

15.5.3.2.3.2. Others

15.5.3.2.4. Diagnostic Centers

15.5.3.2.5. Research Laboratories and Organizations

15.5.3.2.6. Others

15.5.3.3. Rest of Latin America Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type

15.5.3.3.1. Device/Wearable-based

15.5.3.3.2. Mobile App-based

15.6. Key Segment for Channeling Investments

15.6.1. By Country

15.6.2. By Application

15.6.3. By End-User

15.6.4. By Type

16. Competitive Benchmarking

16.1. Market Share Analysis, 2019

16.2. Global Presence and Growth Strategies

16.2.1. Mergers and Acquisitions

16.2.2. Product Launches

16.2.3. Investments Trends

16.2.4. R&D Initiatives

17. Player Profiles

17.1. AliveCor, Inc.

17.1.1. Company Details

17.1.2. Company Overview

17.1.3. Product Offerings

17.1.4. Key Developments

17.1.5. Financial Analysis

17.1.6. SWOT Analysis

17.1.7. Business Strategies

17.2. CapsoVision, Inc.

17.2.1. Company Details

17.2.2. Company Overview

17.2.3. Product Offerings

17.2.4. Key Developments

17.2.5. Financial Analysis

17.2.6. SWOT Analysis

17.2.7. Business Strategies

17.3. Digital Diagnostics Inc.

17.3.1. Company Details

17.3.2. Company Overview

17.3.3. Product Offerings

17.3.4. Key Developments

17.3.5. Financial Analysis

17.3.6. SWOT Analysis

17.3.7. Business Strategies

17.4. dSPACE GmbH

17.4.1. Company Details

17.4.2. Company Overview

17.4.3. Product Offerings

17.4.4. Key Developments

17.4.5. Financial Analysis

17.4.6. SWOT Analysis

17.4.7. Business Strategies

17.5. Eyenuk, Inc.

17.5.1. Company Details

17.5.2. Company Overview

17.5.3. Product Offerings

17.5.4. Key Developments

17.5.5. Financial Analysis

17.5.6. SWOT Analysis

17.5.7. Business Strategies

17.6. hearX IP (Pty) Ltd

17.6.1. Company Details

17.6.2. Company Overview

17.6.3. Product Offerings

17.6.4. Key Developments

17.6.5. Financial Analysis

17.6.6. SWOT Analysis

17.6.7. Business Strategies

17.7. Hill-Rom Services, Inc.

17.7.1. Company Details

17.7.2. Company Overview

17.7.3. Product Offerings

17.7.4. Key Developments

17.7.5. Financial Analysis

17.7.6. SWOT Analysis

17.7.7. Business Strategies

17.8. Infermedica

17.8.1. Company Details

17.8.2. Company Overview

17.8.3. Product Offerings

17.8.4. Key Developments

17.8.5. Financial Analysis

17.8.6. SWOT Analysis

17.8.7. Business Strategies

17.9. Medtronic

17.9.1. Company Details

17.9.2. Company Overview

17.9.3. Product Offerings

17.9.4. Key Developments

17.9.5. Financial Analysis

17.9.6. SWOT Analysis

17.9.7. Business Strategies

17.10. ResApp Health Limited

17.10.1. Company Details

17.10.2. Company Overview

17.10.3. Product Offerings

17.10.4. Key Developments

17.10.5. Financial Analysis

17.10.6. SWOT Analysis

17.10.7. Business Strategies

17.11. Sight Diagnostics Ltd

17.11.1. Company Details

17.11.2. Company Overview

17.11.3. Product Offerings

17.11.4. Key Developments

17.11.5. Financial Analysis

17.11.6. SWOT Analysis

17.11.7. Business Strategies

17.12. SkinVision

17.12.1. Company Details

17.12.2. Company Overview

17.12.3. Product Offerings

17.12.4. Key Developments

17.12.5. Financial Analysis

17.12.6. SWOT Analysis

17.12.7. Business Strategies

17.13. Teckel Medical

17.13.1. Company Details

17.13.2. Company Overview

17.13.3. Product Offerings

17.13.4. Key Developments

17.13.5. Financial Analysis

17.13.6. SWOT Analysis

17.13.7. Business Strategies

17.14. Other Industry Participants

18. Key Findings

Note: This ToC is tentative and can be changed according to the research study conducted during the course of report completion.

**Exclusive for Multi-User and Enterprise User.

At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.

Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.

Prominent participants in our primary research process include:

Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
Research and development participants, distributors/suppliers and subject matter experts

Secondary Research includes data extracted from paid data sources: